A Commitment to Immunology
-
Chaofan Li, PhD, Wins NIH R01 to Study Lung Immune Cells
Chaofan Li, PhD, an Assistant Professor of Medicine in the Division of Infectious Disease and International Health, recently received an R01 award for his project “Molecular Mechanisms of Protective Lung Resident Memory T Cells.” The award provides over $700,000 in … Read More
-
Justin Taylor, PhD, Named 2026 UVA Pinn Scholar
Justin Taylor, PhD, Resident Member of the Beirne B. Carter Center for Immunology Research and Associate Professor of Medicine, was recently named a 2026 Pinn Scholar. The Pinn Scholarship is one of the highest recognitions that research faculty in the … Read More
-
National Postdoc Appreciation Week Programming
Looking ahead to National Postdoc Appreciation Week, we encourage our postdocs to check out the University’s programming, described below.
-
Cara Hatzinger from Rutkowski Lab Receives an F31 Grant to Study the role of TLR5 signaling as a modulator of FLT3 ligand therapeutic efficacy for ovarian cancer
Cara Hatzinger from Rutkowski Lab just received an F31, Investigating the role of TLR5 signaling as a modulator of FLT3 ligand therapeutic efficacy for the treatment of ovarian cancer. Ovarian cancer is the most fatal gynecological malignancy with most patients … Read More
-
Hogan McKee, MBChB, Shares Career Insights With Local High School
CIC trainee Hogan McKee, MBChB, recently presented to the Monticello High School Science National Honor Society. The Science National Honor Society hosts symposia given by outside speakers to expose high school students to career options in STEM. Dr. McKee, mentored … Read More
-
Two World-Class Postdocs Receive Immunology Innovation Awards
Naomi Bryant, PhD, and Liam Fitzsimmons, PhD, are the two first postdoctoral researchers to receive the CIC’s new Immunology Innovation Awards. These awards recognize the brightest up-and-coming scientists across Immunology and aids in recruiting them to the Center. Bryant was … Read More
Haroldo Rodriguez
Title: Dissecting B and T cell responses targeting a tumor-driving oncoprotein
